Metabolic syndrome in children born small-for-gestational age

María Isabel Hernández1, Verónica Mericq

  • 1Institute of Maternal and Child Disease, School of Medicine, University of Chile, Chile.

Insights

Children born small-for-gestational age (SGA) face higher risks of chronic diseases like metabolic syndrome due to early life factors. Interventions focusing on maternal nutrition and healthy infant growth are crucial.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Public Health

Background:

  • Birth weight and early growth influence long-term health.
  • Small-for-gestational age (SGA) infants are at increased risk for chronic diseases.
  • Intrauterine environment and epigenetic programming play a role in metabolic syndrome development.

Purpose of the Study:

  • To explore the link between SGA birth, rapid infant weight gain, and chronic disease development.
  • To highlight the components of metabolic syndrome and its early onset.
  • To identify key intervention points for preventing chronic diseases in SGA individuals.

Main Methods:

  • Review of existing literature linking SGA, early growth, and metabolic syndrome.
  • Definition of metabolic syndrome criteria (waist circumference, blood pressure, lipids, glucose).
  • Examination of early markers like insulin resistance at one year of age.

Main Results:

  • SGA birth and rapid infant weight gain are associated with metabolic syndrome.
  • Metabolic syndrome components include central obesity, hypertension, dyslipidemia, and hyperglycemia.
  • Insulin resistance, obesity, and type 2 diabetes are more common in SGA individuals.

Conclusions:

  • Early life factors significantly impact the risk of developing chronic diseases.
  • Interventions should focus on maternal nutrition, breastfeeding, and preventing rapid infant weight gain.
  • Promoting a healthy lifestyle from infancy is essential for mitigating risks associated with SGA birth.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...